- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Danish drugs maker halves targets for operating profit growth.
Pharma group Sanofi rises on improved guidance and RBS gains after a third-quarter profit beat.
Forward-looking purchasing managers' indices and earnings from beleaguered lender Deutsche Bank feature among the other release highlights.
Shares in the stock decline only marginally as the pharmaceuticals group sticks with its full-year forecast.